Evidence map›Paper›PMID 38603437›Full record

ArticleTransportation research record2023

Vehicle Design Strategies to Reduce the Risk of COVID-19 Transmission in Shared and Pooled Travel: Inventory, Typology, and Considerations for Research and Implementation.

Angela Sanguinetti, Ashley DePew, Kate Hirschfelt

Open access · bronzeAbstract read
In one paragraph

Article in Transportation research record, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
1.2field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 3 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Angela SanguinettiInstitute of Transportation Studies, University of California, Davis, CA.ORCID https://orcid.org/0000-0002-9008-7175
Ashley DePewInstitute of Transportation Studies, University of California, Davis, CA.ORCID https://orcid.org/0000-0002-8398-7319
Kate HirschfeltInstitute of Transportation Studies, University of California, Davis, CA.
University of California, Davis · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The global COVID-19 pandemic has given rise to a plethora of ideas for modifying and redesigning public transportation and shared mobility vehicles to protect workers and riders from contracting the disease while traveling. This research seeks to inventory these strategies, and to organize and distill them in a way that enables researchers, policymakers, and public transport and mobility service operators to more systematically and efficiently evaluate them. Through literature search and analysis, the COVID-19 risk-mitigating vehicle design (CRVD) typology was developed, articulating 12 categories of strategies (e.g., Seating Configuration, Barriers) and 12 mechanisms (e.g., physical distancing, physical separation) by which the strategies may reduce COVID-19 spread. A secondary contribution of this research is to gather opinions of experts in fields related to COVID-19 and its transmission, about the identified CRVD strategies and mitigation mechanisms. The typology and expert opinions serve as a launching point for further innovation and research to evaluate the effectiveness of CRVD strategies and their relationship to user preferences and travel behavior, within and beyond the current context. Public transport and shared mobility service operators can use the CRVD typology as a reference, in conjunction with industry guidance and emerging research on strategy effectiveness, to aid decision-making in their continued response to the pandemic as well as for future planning.

Indexed as

air quality and health impactsplanning and preparednesspublic and population healthtransportation and public healthtransportation systems resiliencevulnerable populations

Identifiers

PMID38603437
PMCPMC9852963
OpenAlexW4319833049

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.